TY - JOUR
T1 - Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis
AU - Navalpotro-Gómez, Irene
AU - Vivanco-Hidalgo, Rosa María
AU - Cuadrado-Godia, Elisa
AU - Medrano-Martorell, Santiago
AU - Alameda-Quitllet, Francisco
AU - Villalba-Martínez, Gloria
AU - Roquer, Jaume
PY - 2016/8/15
Y1 - 2016/8/15
N2 - © 2016 Elsevier B.V. All rights reserved. Background Idiopathic hypertrophic cranial pachymeningitis (IHCP) is an uncommon disease of unknown etiology characterized by thickening of the cerebral dura mater with possible associated inflammation. The most frequently described clinical symptoms include headache, cranial nerve palsy, and cerebellar dysfunction. Epilepsy and/or status epilepticus as main presentation is very uncommon. Case presentation Two consecutive cases are presented of patients manifesting focal status epilepticus secondary to IHCP, with clinical, laboratory [blood test and cerebrospinal fluid (CSF) analysis], neuroradiologic [magnetic resonance imaging (MRI) at 3 Tesla and digital subtraction angiography (DSA)], and therapeutic data. One patient underwent meningeal biopsy; pathology findings are also included. Corticosteroid therapy resulted in clinical improvement in both cases, and neuroimaging showed decreased abnormal morphology, compared to initial findings. Conclusion In the diagnostic approach to focal status epilepticus or epilepsy, IHCP must be considered a potential, although extremely infrequent, cause. Anti-inflammatory treatment is an effective addition to antiepileptic drug therapy in patients with IHCP.
AB - © 2016 Elsevier B.V. All rights reserved. Background Idiopathic hypertrophic cranial pachymeningitis (IHCP) is an uncommon disease of unknown etiology characterized by thickening of the cerebral dura mater with possible associated inflammation. The most frequently described clinical symptoms include headache, cranial nerve palsy, and cerebellar dysfunction. Epilepsy and/or status epilepticus as main presentation is very uncommon. Case presentation Two consecutive cases are presented of patients manifesting focal status epilepticus secondary to IHCP, with clinical, laboratory [blood test and cerebrospinal fluid (CSF) analysis], neuroradiologic [magnetic resonance imaging (MRI) at 3 Tesla and digital subtraction angiography (DSA)], and therapeutic data. One patient underwent meningeal biopsy; pathology findings are also included. Corticosteroid therapy resulted in clinical improvement in both cases, and neuroimaging showed decreased abnormal morphology, compared to initial findings. Conclusion In the diagnostic approach to focal status epilepticus or epilepsy, IHCP must be considered a potential, although extremely infrequent, cause. Anti-inflammatory treatment is an effective addition to antiepileptic drug therapy in patients with IHCP.
KW - Cerebral edema
KW - Dural enhancement
KW - Focal seizures
KW - Idiopathic hypertrophic pachymeningitis
KW - Status epilepticus
UR - https://www.scopus.com/pages/publications/84974588658
U2 - 10.1016/j.jns.2016.06.025
DO - 10.1016/j.jns.2016.06.025
M3 - Article
SN - 0022-510X
VL - 367
SP - 232
EP - 236
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
ER -